Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonyl-methoxyethyl)adenine (PMEA)
- 31 July 1991
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 16 (1), 77-92
- https://doi.org/10.1016/0166-3542(91)90060-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Anti‐retrovirus activity of 9‐(2‐phosphonylmethoxyethyl)adenine (pmea) in vivo increases when it is less frequently administeredInternational Journal of Cancer, 1990
- Inhibitory effects of 9‐(2‐Phosphonylmethoxyethyl)adenine and 3′‐azido‐2′,3′‐dideoxythymidine on tumor development in mice inoculated intracerebrally with moloney murine sarcoma virusInternational Journal of Cancer, 1990
- 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infectionsAntimicrobial Agents and Chemotherapy, 1989
- Molecular Cloning of a Feline Leukemia Virus That Induces Fatal Immunodeficiency Disease in CatsScience, 1988
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Experimental transmission and pathogenesis of immunodeficiency syndrome in catsBlood, 1987
- Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compoundsCollection of Czechoslovak Chemical Communications, 1987
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDSNature, 1986
- Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27Journal of Immunological Methods, 1983